StonvexLoading…
StonvexStonvexStonvexCore line items from ALL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $15.76B | $16.94B | $67.69B | $17.25B | $16.63B |
Operating Income | Not available | Not available | $13.16B | Not available | Not available |
Net Income | Not available | $2.46B | $10.28B | $6.45B | $2.70B |
EPS (Diluted) | $4.65 | $9.25 | $38.06 | $13.95 | $7.76 |
Total Assets | Not available | $123.97B | $119.76B | $120.40B | $115.89B |
Total Liabilities | Not available | $92.39B | $89.17B | $92.91B | $91.89B |
Cash & Equivalents | Not available | $697.00M | $678.00M | $931.00M | $995.00M |
Free Cash Flow OCF − CapEx | Not available | $3.52B | $9.88B | $6.98B | $3.75B |
Shares Outstanding | Not available | 258.00M | 260.00M | 262.00M | 264.00M |